日本語 
Biotech
Boston Medical Sciences Co., Ltd. is pleased to announce that it has raised 930 million yen in a Series A round with new investors including JIC Venture Growth Investments Co.,…
Latest News
Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth
Celaid Therapeutics Inc. announced that it successfully completed the first close of…
Hinge Bio partners with Kyorin to Develop HB2198 in Japan
Hinge Bio, Inc., a private biotech firm that focuses on multispecific antibody…
Celaid Therapeutics and AGC sign iPSC-HSPC research deal
Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…
Asahi Kasei Opens New Plant to Boost Planova Output
Asahi Kasei Life Science will build a new spinning plant in Nobeoka…
Pahr Therapeutics secures $14M to develop PAH therapies
Pahr Therapeutics has raised $14 million in seed funding. This money will…
Alloy Therapeutics, KSAC team up to grow Japan Biotechs
Alloy Therapeutics Co. Ltd. (Alloy Japan) signed a Memorandum of Understanding (MOU)…
NKGen and HekaBio team up on NK Cell therapy in Japan
NKGen Biotech, Inc. is a clinical-stage biotech firm. They focus on NK…
Quantum Biology: Japan’s Role in the Next Medical Frontier
For many years, Japan has been a world leader in precision, innovation,…
Latest Article
English